Bone Health in Gynecologic Cancers-does FOSAVANCE Help?

NCT00593580 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: placebo
DRUG: alendronate/cholecalciferol

Sponsor

British Columbia Cancer Agency